Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year revenue growth rate
Percentile
P67
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.75% |
| Q3 2025 | 157.02% |
| Q2 2025 | -19.67% |
| Q1 2025 | 3.11% |
| Q4 2024 | -74.51% |
| Q3 2024 | -16.73% |
| Q2 2024 | 51.56% |
| Q1 2024 | -78.33% |
| Q4 2023 | 1851.91% |
| Q3 2023 | -4.92% |
| Q2 2023 | -96.77% |
| Q1 2023 | 9808.39% |
| Q4 2022 | -103.77% |
| Q3 2022 | 5670.51% |
| Q2 2022 | 8.21% |
| Q1 2022 | -97.66% |
| Q4 2021 | 1794.26% |
| Q3 2021 | 9.21% |
| Q2 2021 | -79.13% |
| Q1 2021 | -0.55% |
| Q4 2020 | -94.45% |
| Q3 2020 | 310.87% |
| Q2 2020 | 58.75% |
| Q1 2020 | -44.71% |
| Q4 2019 | 59.91% |
| Q3 2019 | -55.66% |
| Q2 2019 | 786.80% |
| Q1 2019 | 158.81% |
| Q4 2018 | -4.11% |
| Q3 2018 | -18.68% |
| Q2 2018 | 173.35% |
| Q1 2018 | -85.15% |
| Q4 2017 | 452.70% |
| Q3 2017 | -2.46% |
| Q2 2017 | -19.60% |
| Q1 2017 | -38.02% |
| Q4 2016 | -28.60% |
| Q3 2016 | -11.08% |
| Q2 2016 | -22.98% |
| Q1 2016 | -2.17% |